Lipase Test · Blood

If you have ever had sudden, severe upper abdominal pain, your doctor likely ordered a lipase test. That single number can confirm or rule out acute pancreatitis with remarkable accuracy. But lipase also tells a subtler story: persistently low levels may signal chronic pancreatic damage or metabolic trouble that standard blood panels never check for.

Lipase is a protein enzyme your pancreas produces to break down dietary fat. When the pancreas is injured or inflamed, lipase floods into the bloodstream, and the spike is both fast and specific. Understanding your lipase level, whether it is high, low, or trending in a direction, gives you a direct window into an organ that most routine lab work ignores entirely.

What Lipase Is and Where It Comes From

Lipase (pancreatic lipase) is a protein enzyme, not a hormone. Its job is to break apart triglycerides (the main form of dietary fat) into smaller fatty acids and a molecule called glycerol, which your intestines can then absorb. The pancreas is the dominant source of lipase in your blood. Smaller amounts come from the stomach, intestines, liver, heart, lungs, and certain white blood cells, but the pancreas produces so much more that a blood lipase test effectively reflects pancreatic health.

Your body also makes other lipase family members with different jobs. Lipoprotein lipase clears fat particles from your bloodstream. Hormone-sensitive lipase breaks down stored fat inside fat cells. These are biologically related but are not what a standard serum lipase test measures. When your lab reports "lipase," it is quantifying the pancreatic enzyme in your blood.

Acute Pancreatitis: The Primary Reason to Test

Acute pancreatitis, a sudden inflammation of the pancreas, is the most common reason lipase is ordered. The standard diagnostic rule, used by guidelines worldwide, requires two of three features: characteristic abdominal pain, imaging findings, and a lipase level at or above three times the upper limit of normal (ULN) set by your lab. At that threshold, lipase catches about 64% to 100% of acute pancreatitis cases (with modern assays performing at the higher end of this range) while correctly clearing about 99% of people who do not have it.

One retrospective study of 151 patients found that lipase correctly identified 96.6% of pancreatitis cases and correctly ruled it out in 99.4% of people without the disease. Lipase also detected an additional 12% of gallstone-related and 23% of alcohol-related pancreatitis cases that amylase (the older, more commonly known pancreatic enzyme test) missed entirely. Across the broader evidence base, lipase has reached 100% detection in alcohol-related pancreatitis, compared to as low as 55% for amylase.

If you have unexplained upper abdominal pain, lipase is the single most informative blood test you can order. It stays elevated longer than amylase after an attack begins, giving you a wider window to catch the problem.

What a High Lipase Can Mean Beyond Pancreatitis

A lipase above three times the ULN does not always mean pancreatitis. A systematic review found that significant lipase elevations also occur in kidney impairment, a rare condition called macrolipase (where lipase binds to other proteins and clears slowly), liver and bile duct disease, intestinal conditions, cancer, diabetes, drug reactions, infections, and critical illness. In one hospital study, about 24% to 30% of patients with lipase above three times ULN plus abdominal pain had no imaging evidence of pancreatitis at all.

This matters if you see a high result on your lab report. A single elevated reading does not automatically mean your pancreas is inflamed. Context, including symptoms, imaging, and kidney function, determines the real significance.

What Low Lipase Can Tell You

Most people think of lipase as a test that matters only when it is high. That is a misconception. A systematic review and meta-analysis found that low serum levels of both amylase and lipase are significantly associated with type 2 diabetes, type 1 diabetes, excess body fat, and metabolic syndrome (a cluster of conditions including high blood sugar, high blood pressure, and abnormal cholesterol). Low lipase may reflect a pancreas that has been quietly damaged over years by metabolic stress.

Low lipase is also quite specific for chronic pancreatitis. In one study, a lipase below 20 U/L detected about half of chronic pancreatitis cases (54.5% sensitivity) and correctly ruled it out in about two-thirds of people without it (68.8% specificity). Combining low amylase and low lipase together pushed the rate of correctly ruling out non-cases as high as 88.8% to 93.5%. If your lipase is persistently at the bottom of the reference range, that finding deserves attention, not dismissal.

Heart Failure and Critical Illness

An unexpected finding from a study of 146 patients admitted to intensive care with acute decompensated heart failure (a sudden worsening of heart function) showed that those with the lowest lipase levels, in the bottom quarter, had roughly twice the risk of death or readmission compared to patients with higher levels. After adjusting for age, heart failure history, and other lab values, the association held. This suggests that in heart failure, a low lipase may reflect poor blood flow to the pancreas or broader metabolic decline.

During the COVID-19 pandemic, researchers discovered that elevated lipase was common among hospitalized patients. A meta-analysis of 21 studies covering over 36,000 patients found that about 25% had elevated pancreatic enzymes, and those patients had higher rates of ICU admission, mechanical ventilation, and death. In one large cohort of 3,244 hospitalized COVID-19 patients, high lipase at admission independently predicted mortality (about three times the odds of death compared to those with normal lipase). Whether this reflects direct viral injury to the pancreas or a broader marker of body-wide inflammation remains debated.

Reference Ranges

Lipase reference ranges are set by each lab based on its specific assay and local healthy population. There is no single universal number. Most labs report an upper limit of normal (ULN) somewhere between 60 and 160 U/L, but the exact value depends on your lab's equipment and calibration. Always compare your result to your own lab's reference range, not to numbers from other sources.

The clinically meaningful thresholds are expressed as multiples of whatever your lab's ULN is, not as fixed numbers.

Compare your results within the same lab over time for the most meaningful trend.

When Results Can Be Misleading

Lipase has a within-person biological variation of about 7.7%, based on a well-controlled European study of 91 healthy adults sampled weekly for 10 weeks. That means your lipase can fluctuate by roughly 8% from one draw to the next even when nothing has changed clinically. Between different healthy people, the variation is much wider, around 23.8%, which is why a single reading needs to be compared to your own baseline rather than someone else's.

• Kidney impairment: reduced clearance of lipase from the blood can raise your measured level without any pancreatic problem. Lipase rises with advancing chronic kidney disease stage.
• Macrolipase: in rare cases, lipase binds to immune system antibodies (called immunoglobulins) in the blood, creating a larger complex that clears slowly. This produces a persistently elevated lipase that looks alarming but does not indicate pancreatic disease.
• Critical illness and body-wide inflammation: severe infections, overwhelming body-wide infection (sepsis), or major surgery can raise lipase through impaired organ blood flow and generalized tissue stress, not through direct pancreatic injury.
• Immune checkpoint inhibitors (ICIs): cancer immunotherapy drugs can cause genuine pancreatic injury, but in a large cohort of 6,450 ICI-treated patients, only 29% of lipase elevations were actually attributed to the drug itself. The rest were caused by gallstones, metastases, bowel problems, or infections.

Sample handling also matters. Lipase stability depends on how quickly your blood is processed, the type of collection tube used, and the storage temperature. If your sample sits at room temperature for too long before being spun down and analyzed, the result may not reflect your true level.

Lipase vs. Amylase: Why Lipase Wins

Amylase is the older, more familiar pancreatic enzyme test, but the evidence strongly favors lipase. Lipase is more sensitive (catches more true cases), stays elevated longer after an attack, and performs especially well in alcohol-related pancreatitis where amylase often misses the diagnosis. Multiple studies and reviews conclude that ordering amylase alongside lipase adds no meaningful diagnostic value. One large institutional analysis found zero acute pancreatitis cases that would have been missed by ordering lipase alone.

Despite this evidence, many hospitals still order both tests by default, adding cost without improving accuracy. If you are ordering your own testing, lipase alone is sufficient for screening pancreatic health.

Tracking Your Trend

A single lipase reading is a snapshot. Given the 7.7% within-person variability and the many non-pancreatic factors that can shift the number, a single value in isolation tells you less than you might expect. What matters more is your trajectory over time.

If you are checking lipase as part of a broader metabolic or digestive health assessment, get a baseline when you are feeling well, fasted, and free of acute illness. If that baseline is normal and you have no symptoms, annual rechecking is reasonable as part of a digestive health screen. If you have risk factors for pancreatitis (heavy alcohol use, gallstones, very high triglycerides, a family history of pancreatic disease), consider checking every six months.

A lipase that is slowly drifting downward over several readings, particularly toward the very low end of the range, may be an early signal of chronic pancreatic insufficiency or metabolic disease worth investigating, even if each individual value is technically "normal."

What to Do With an Abnormal Result

If your lipase comes back above three times your lab's ULN and you have abdominal pain, that combination warrants urgent evaluation, typically abdominal imaging (CT or ultrasound) and clinical assessment. Do not wait to retest. Acute pancreatitis can range from mild and self-limited to life-threatening, and early intervention with fluids and pain control improves outcomes.

If your lipase is mildly elevated (one to three times ULN) without symptoms, the most productive next steps are checking your kidney function (creatinine, cystatin C, and eGFR, which together estimate how well your kidneys filter waste) to rule out reduced clearance, reviewing your medications for known offenders, and repeating the test in two to four weeks to see if it normalizes. Persistent mild elevation without a clear cause may warrant a gastroenterologist's input.

If your lipase is persistently low, order a comprehensive metabolic panel, fasting glucose, HbA1c, and triglycerides. A low lipase alongside abnormal blood sugar markers or signs of metabolic syndrome suggests the pancreas may be under chronic stress. A gastroenterologist or endocrinologist can help determine whether further pancreatic function testing (such as fecal elastase, a stool test that measures how well the pancreas produces digestive enzymes) is warranted.